Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014.

Archives of virology - 1 Sept 2016

Naziri Hamed, Baesi Kazem, Moradi Abdolvahab, Aghasadeghi Mohammad R, Tabarraei Alijan, McFarland Willi, Davarpanah Mohamad Ali

Abstract excerpt

Resistance to antiretroviral agents is a significant concern in the clinical management of HIV-infected individuals, particularly in areas of the world where treatment options are limited. In this study, we aimed to identify HIV drug-resistance-associated mutations in 40 drug-naïve patients and 62 patients under antiretroviral therapy (ART) referred to the Shiraz HIV/AIDS Research Center - the first such data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Viral

Share to Gene Expression Regulation, Viral

Share to HIV Infections

Share to Human Immunodeficiency Virus Proteins

Source

Identifiers

PMID: 27368990
DOI: 10.1007/s00705-016-2955-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014.PMID 27368990Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.Semantic proximity Read ↗

Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients.Semantic proximity Read ↗

Human Immunodeficiency Virus-1 Drug Resistance Mutations in Iranian Treatment-experienced Individuals.Semantic proximity Read ↗

A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 PatientsSemantic proximity Read ↗

Antiretroviral drug resistance among antiretroviral‐naïve and treatment experienced patients infected with HIV in IranSemantic proximity Read ↗

HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.Semantic proximity Read ↗

The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.Semantic proximity Read ↗

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.Semantic proximity Read ↗

Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.Semantic proximity Read ↗

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.Semantic proximity Read ↗

Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.